Grants and Contracts Details
Description
IgA nephropathy (IgAN) represents the leading cause of kidney failure among young
adults, and the most frequent form of primary glomerulonephritis worldwide. Our recent
studies define IgAN as an autoimmune trait of complex architecture with a strong
genetic determination. We have recently discovered several common genetic variants
predisposing to IgAN in adults through a large-scale genome-wide association study
(GWAS). We also discovered a strong relationship between the load of GWAS-identified
risk alleles and the age of disease onset, suggesting that pediatric patients with IgAN
may carry a significantly higher burden of genetic risk factors. Accordingly, we would
like to extend our genetic investigations to children affected by IgAN and Henoch-
Schönlein purpura (HSP) without or with nephritis (HSPN), two IgA-related syndromes
with skin manifestations. This proposal aims at (1) validation of adult genetic and
biochemical disease predictors in pediatric patients with IgAN and HSP with and without
nephritis, and (2) discovery of new genetic and biomarker predictors of disease based
on pediatric cohorts.
Status | Active |
---|---|
Effective start/end date | 7/24/23 → 12/30/25 |
Funding
- Pediatric Nephrology Research Consortium Incorporated: $25,312.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.